课题基金 / 基金详情

Novel Computation Methods for the Analysis of Cell-Free DNA Sequence Data

Novel Computation Methods for the Analysis of Cell-Free DNA Sequence Data
用于分析无细胞 DNA 序列数据的新计算方法
批准号:
10238894
负责人:
Steven M. Dubinett
金额:
$55.22万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2023-08-31

项目摘要

项目成果

Steven M. Dubinett的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Non-invasive detection of cell-free DNA(cfDNA) promises to impact clinical regimens of a wide range of diseases, e.g. prenatal conditions, cancer, transplantation, autoimmune disease, trauma, and cardiovascular disease. While this field is emerging as one of the most promising and exciting areas of medicine, few bioinformatics tools are available to facilitate the information extraction from cfDNA sequencing data, although cfDNA data possesses many unique properties. In this proposal, we aim to generate a suite of computational methods facilitating the analysis and interpretation of cfDNA sequencing data, and demonstrate its utilities in cancer detection and characterization. Specifically, we will develop computational methods for the following applocations: (1) Ultra-sensitively detect and locate multiple types of cancer using cfDNA methylome; (2) Detect Copy Number Variation (CNV) in cfDNA sequencing data; (3) Annotate Single Nucleotide Variations (SNV) in cfDNA sequencing data. These computational tools will be validated with cfDNA samples collected from a cohort of lung cancer patients participating in an immunotherapy clinical trial, a repository of blood samples from patients with different types of cancer, and a cohort of liver cancer patients. Although we use cancer as the main context for developing these applications, many of the methods can be adapted to other diseases, e.g. prenatal diagnosis and organ transplant monitoring. We expect that the above open-source tools will significantly facilitate cfDNA- based disease diagnosis and monitoring. 1
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Early detection of metastatic disease in US Veterans following surgery for early stage lung cancer
Exosome-mediated mechanisms of metastatic disease in non-small cell lung cancer
Exosome-mediated mechanisms of metastatic disease in non-small cell lung cancer
Exosome-mediated mechanisms of metastatic disease in non-small cell lung cancer
海外基金